ALDH2 Mutation in Taiwanese Head and Neck Cancer

NCT02761408 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-05-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of ALDH2 mutation in radiation associating dermatitis or mucositis in head and neck cancer patients who accept chemoradiation therapy

Conditions

Sponsors & Collaborators

  • Taipei Veterans General Hospital, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Ling-Wei Wang, MD · Cancer Center, Taipei Veterans General Hospital

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-04-30
Completion
2018-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02761408 on ClinicalTrials.gov